Charles River Laboratories International, Inc. (CRL)
NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
| Previous Close | 231.77 |
| Open | 234.15 |
| Bid | 92.60 x 900 |
| Ask | 259.99 x 1100 |
| Day's Range | 226.28 - 236.11 |
| 52 Week Range | 217.20 - 460.21 |
| Volume | |
| Avg. Volume | 565,191 |
| Market Cap | 11.74B |
| Beta (5Y Monthly) | 1.23 |
| PE Ratio (TTM) | 30.13 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Business Wire
Charles River Laboratories Announces First-Quarter 2022 Results
WILMINGTON, Mass., May 04, 2022--Charles River Laboratories Announces First-Quarter 2022 Results
- Business Wire
Charles River and Valo Launch Logica, an Integrated AI-Powered Drug Discovery Solution to Rapidly Deliver Optimized Preclinical Assets
WILMINGTON, Mass. & BOSTON, April 27, 2022--Charles River and Valo have launched Logica, an AI-powered drug solution that translates biological insights into optimized preclinical assets.
- Business Wire
Charles River Laboratories Schedules First-Quarter 2022 Earnings Release and Conference Call
WILMINGTON, Mass., April 13, 2022--Charles River Laboratories International, Inc. (NYSE: CRL) will release first-quarter 2022 financial results on Wednesday, May 4th, before the market opens. A conference call has been scheduled to discuss this information on Wednesday, May 4th, at 9:30 a.m. ET.
© 2022 Yahoo. All rights reserved.
